Group 1: Eli Lilly - Eli Lilly is recognized for its innovative culture and strong market position in diabetes medicines, with significant breakthroughs over the years [3][4] - The company is expanding into the weight management market, with Zepbound leading and several promising candidates in development, including Orforglipron [5][6] - Eli Lilly has a robust network within the healthcare industry, including relationships with hospitals and payers, enhancing its competitive advantage [7] - The company has increased its dividend payouts by 200% over the past decade, positioning itself well for future growth as demand for lifesaving medicines rises [8] Group 2: Veeva Systems - Veeva Systems specializes in cloud services tailored for the life sciences industry, successfully carving out a niche in a competitive market [9][10] - The cloud computing industry is expected to continue growing, with advancements in artificial intelligence contributing to its long-term growth potential [11] - The life sciences industry is also projected to expand due to an aging population and increased demand for medical products, benefiting Veeva Systems [12] - Veeva Systems enjoys strong competitive advantages due to high switching costs for life science companies, ensuring its leadership in the niche market [13][14]
2 Top Growth Stocks to Buy and Hold for the Next 20 Years